Influenza (seasonal)

Rite Aid-NFID survey suggests most U.S. women not up-to-date on vaccinations

Rite Aid and the National Foundation for Infectious Diseases (NFID)recently conducted a survey that suggests most U.S. adult women do not believe they are up to date on their vaccinations.
 
Undefined

Grippe : regain d'intérêt pour le vaccin... la faute à Ebola ?

Le nombre de personnes souhaitant se faire vacciner contre la grippe repart à la hausse, notamment chez les plus de 65 ans qui sont plus de 36% à vouloir se prémunir contre le virus, selon Europe 1. Une tendance en augmentation qui s'expliquerait notamment par la forte médiatisation du virus Ebola.
 
Undefined

FDA approves new prescribing information for Fluzone High-Dose flu vaccine

The U.S. Food and Drug Administration recently approved Sanofi Pasteur’s request to include data in the prescribing information for its Fluzone High-Dose flu vaccine that shows it is more effective in protecting older patients.
 
A new study, published in the Aug. 14 issue of The New England Journal of Medicine, showed that Fluzone High-Dose protects better than Fluzone’s standard dose in adults 65 and older.
 
Undefined

Grippe : non, il n'y a pas de produits toxiques dans le vaccin

La grippe tue chaque année en France 9000 personnes âgées de plus de 65 ans. Pourtant, seuls 29% des Français prévoient de se faire vacciner cet hiver, a révélé une étude PHR-Ifop. Notamment parce qu'ils jugent ce vaccin trop risqué. "Ce n'est pas une peur de la piqûre mais une peur du produit", souligne à metronews Christophe Koperski, membre de la Fédération des pharmaciens d'officine. Vous êtes inquiet de ce qu'on vous inocule ? Voici les ingrédients du vaccin contre la grippe. 

Undefined

Could oral vaccines shake up the flu shot market? Vaxart's Ph I says maybe

Flu shots are a driving sales force for more than a couple of vaccine players. But could an oral alternative disrupt the flu vaccine market down the line?
 
New data from Vaxart suggest it's possible. In a Phase I study, its H1N1 tablet vaccine generated protective immunity that measured up to on-the-market options, as measured by hemagglutinin inhibition assay.
 
Undefined

Vaccine ignorance -- deadly and contagious

In the absence of credible, strong political leadership, paranoia about disease can go viral. We've seen this happen around the world with a wide range of illnesses, from swine flu to SARS to Ebola.
 
And even after threats are addressed, a new form of conspiratorial thinking often emerges, this time focused not on the microbes but on the tools used to keep the germs at bay — especially vaccines.
 
Undefined

Vaxart’s oral flu vaccine shows promise

Vaxart, Inc., released clinical results on Tuesday that showed its H1N1 tablet vaccine is just as reliable as currently licensed flu vaccines.
 
Undefined

ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP) MEETING

From the US Centers for Disease Control and Prevention (US CDC) website:
Undefined

Sanofi Pasteur Introduces 4-Strain Influenza Vaccine (Fluzone) in Canada

Sanofi Pasteur, the vaccines division of Sanofi, is pleased to announce the launch of its 4-strain influenza vaccine (Fluzone® Quadrivalent) in Canada. This new vaccine was introduced in the United States in 2013 and is quickly becoming the new standard of care for the prevention of influenza. Licensed for use in individuals six months of age and older, Fluzone® Quadrivalent vaccine provides improved protection against influenza, and will be available in Canada starting this flu season.
 
Undefined

Pages